DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pipendoxifene
Pipendoxifene
Nitrate Prodrugs Able to Release Nitric Oxide in a Controlled and Selective
The Role of Sevista in the Management of Dysfunctional Uterine Bleeding Section Obstetrics & Gynaecology
Tanibirumab (CUI C3490677) Add to Cart
Modifications to the Harmonized Tariff Schedule of the United States To
Screening of Clinically Approved and Investigation Drugs As Potential
Design and Synthesis of Selective Estrogen Receptor Β Agonists and Their Hp Armacology K
(12) United States Patent (10) Patent No.: US 8,853,266 B2 Dalton Et Al
IGFBP2-Biomarker
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
ICNMD XIII 13Th International Congress on Neuromuscular
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy Resistant Breast Cancer
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0022235 A1
(10) Patent No.: US 8080682 B2
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Screening of Clinically Approved and Investigation Drugs As Potential Inhibitors of COVID-19 Main Protease: a Virtual Drug Repurposing Study
Download5 MB
Selective Estrogen Receptor Modulators Œ an Update
Top View
Pharmaabkommen A1 E
Supporting Information
Estrogen Receptor/ERR
(12) Patent Application Publication (10) Pub. No.: US 2016/0082123 A1 RAU Et Al
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
(12) Patent Application Publication (10) Pub. No.: US 2013/0035635 A1 Rau Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
Treatment of Hot Flushes, Vasomotor Symptoms, and Night Sweats with Sex Steroid Precursors in Combination with Selective Estrogen Receptor Modulators
Ep 2106212 B1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Stereo-Specific Lasofoxifene Derivatives Reveal the Interplay Between Estrogen Receptor Alpha Stability and Antagonistic Activit
The Pharmacological Effects of Estrogen Receptor Alpha Y537S and D538G Mutations 3621 Steven J